A002264 revised AU-VU:EOAS Encyclopedia of Australian Science and Innovation

All key entry types: Awards; Concepts; Corporate Bodies (Organisations); Cultural Artefacts; People; etc

These key entries are listed separately below with other indexes and lists.

 English AACR2 Anglo-American Cataloguing Rules Corporate Body created 2004-11-17 human Emily Geraghty & Annette Alafaci updated 2024-04-30 human https://www.eoas.info/biogs/A002264b.htm corporateBody Molecular Genetics of Cancer Division The Walter and Eliza Hall Institute of Medical Research AACR2 1996 Medical Research In the major Institute restructure of 1996/1997 the Molecular Genetics of Cancer Division evolved from the Molecular Biology Unit. Today the Division's major areas of research are control of cell death (apoptosis), genetic basis of malignancy and differentiation and proliferation. The main goal of this research is to develop new and improved cancer therapies.

Research in the Molecular Genetics of Cancer Division examines the genetic programs that govern normal cell behaviour. These include cell differentiation and the regulation of cell apoptosis or programmed cellular suicide. The main diseases targeted by the Division are cancers of the blood, leukaemias and lymphomas, and breast cancer (as part of the Victorian Breast Cancer Research Consortium). Much of their work involves the development, characterisation and use of novel tumour-prone strains of mice.

 Molecular Biology Unit, The Walter and Eliza Hall Institute of Medical Research (1981 - 1996) The Walter and Eliza Hall Institute of Medical Research (1915 - )

Trove

 'Molecular Genetics of Cancer Division', in Encyclopedia of Australian Science and Innovation, Centre for Transformative Innovation, Swinburne University of Technology Molecular Genetics of Cancer Division Swinburne University of Technology, Centre for Transformative Innovation Encyclopedia of Australian Science and Innovation